1. Home
  2. ALT vs ZEUS Comparison

ALT vs ZEUS Comparison

Compare ALT & ZEUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • ZEUS
  • Stock Information
  • Founded
  • ALT 1997
  • ZEUS 1954
  • Country
  • ALT United States
  • ZEUS United States
  • Employees
  • ALT N/A
  • ZEUS N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • ZEUS Metal Fabrications
  • Sector
  • ALT Health Care
  • ZEUS Industrials
  • Exchange
  • ALT Nasdaq
  • ZEUS Nasdaq
  • Market Cap
  • ALT 327.4M
  • ZEUS 367.1M
  • IPO Year
  • ALT N/A
  • ZEUS 1994
  • Fundamental
  • Price
  • ALT $3.59
  • ZEUS $33.12
  • Analyst Decision
  • ALT Strong Buy
  • ZEUS Buy
  • Analyst Count
  • ALT 6
  • ZEUS 1
  • Target Price
  • ALT $17.40
  • ZEUS $38.00
  • AVG Volume (30 Days)
  • ALT 2.5M
  • ZEUS 52.9K
  • Earning Date
  • ALT 11-11-2025
  • ZEUS 10-30-2025
  • Dividend Yield
  • ALT N/A
  • ZEUS 1.94%
  • EPS Growth
  • ALT N/A
  • ZEUS N/A
  • EPS
  • ALT N/A
  • ZEUS 1.23
  • Revenue
  • ALT $20,000.00
  • ZEUS $1,878,204,000.00
  • Revenue This Year
  • ALT N/A
  • ZEUS $0.48
  • Revenue Next Year
  • ALT $761,880.20
  • ZEUS $2.77
  • P/E Ratio
  • ALT N/A
  • ZEUS $26.92
  • Revenue Growth
  • ALT N/A
  • ZEUS N/A
  • 52 Week Low
  • ALT $2.90
  • ZEUS $26.32
  • 52 Week High
  • ALT $11.16
  • ZEUS $43.60
  • Technical
  • Relative Strength Index (RSI)
  • ALT 44.54
  • ZEUS 51.34
  • Support Level
  • ALT $3.60
  • ZEUS $32.09
  • Resistance Level
  • ALT $3.82
  • ZEUS $33.85
  • Average True Range (ATR)
  • ALT 0.17
  • ZEUS 1.00
  • MACD
  • ALT 0.02
  • ZEUS -0.04
  • Stochastic Oscillator
  • ALT 47.52
  • ZEUS 49.03

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

Share on Social Networks: